Cargando…

Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis

AIMS: We conducted a systematic review and meta-analysis to assess various antidiabetic agents’ association with mortality in patients with type 2 diabetes (T2DM) who have coronavirus disease 2019 (COVID-19). METHODS: We performed comprehensive literature retrieval from the date of inception until F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kan, Chengxia, Zhang, Yang, Han, Fang, Xu, Qian, Ye, Tongtong, Hou, Ningning, Sun, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481667/ https://www.ncbi.nlm.nih.gov/pubmed/34603199 http://dx.doi.org/10.3389/fendo.2021.708494

Ejemplares similares

Commentary: Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
por: Zhao, Li-Min, et al.
Publicado: (2022)

Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
por: Qu, Na, et al.
Publicado: (2022)

Empagliflozin Attenuates Obesity-Related Kidney Dysfunction and NLRP3 Inflammasome Activity Through the HO-1–Adiponectin Axis
por: Ye, Tongtong, et al.
Publicado: (2022)

Effects of Antidiabetic Drugs on Endothelial Function in Patients With Type 2 Diabetes Mellitus: A Bayesian Network Meta-Analysis
por: Wang, Yuhan, et al.
Publicado: (2022)

The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis
por: Chen, Yidan, et al.
Publicado: (2022)

BAM15 as a mitochondrial uncoupler: a promising therapeutic agent for diverse diseases
por: Xiong, Guoji, et al.
Publicado: (2023)

Cardiovascular mortality and oral antidiabetic drugs: protocol for a systematic review and network meta-analysis
por: Goyat, Rashmi, et al.
Publicado: (2017)

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
por: Chaudhury, Arun, et al.
Publicado: (2017)

Integrated multi-omics analyses reveal effects of empagliflozin on intestinal homeostasis in high-fat-diet mice
por: Shi, Junfeng, et al.
Publicado: (2022)

Relationships Between Perivascular Adipose Tissue and Abdominal Aortic Aneurysms
por: Ye, Tongtong, et al.
Publicado: (2021)

Oral Antidiabetics and Sleep Among Type 2 Diabetes Patients: Data From the UK Biobank
por: Xue, Pei, et al.
Publicado: (2021)

Glycaemic control efficacy of oral antidiabetic drugs in treating type 2 diabetes: a protocol for network meta-analysis
por: Jia, Yongliang, et al.
Publicado: (2015)

Defining the ferroptotic phenotype of beta cells in type 1 diabetes and its inhibition as a potential antidiabetic strategy
por: Markelic, Milica, et al.
Publicado: (2023)

Cardiovascular morbidity and mortality in patients with type 2 diabetes using novel antidiabetic medicines as add-on therapy: an observational real-world study
por: Zerovnik, Spela, et al.
Publicado: (2021)

Antidiabetic and antiosteoporotic pharmacotherapies for prevention and treatment of type 2 diabetes-induced bone disease: protocol for two network meta-analyses
por: Deng, Jiawen, et al.
Publicado: (2020)

Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy
por: Zhang, Le, et al.
Publicado: (2022)

Association of Diabetes Mellitus With Postoperative Complications and Mortality After Non-Cardiac Surgery: A Meta-Analysis and Systematic Review
por: Zhang, Xiaoying, et al.
Publicado: (2022)

Association Between Enterovirus Infection and Type 1 Diabetes Risk: A Meta-Analysis of 38 Case-Control Studies
por: Wang, Kan, et al.
Publicado: (2021)

Calycosin induces autophagy and apoptosis via Sestrin2/AMPK/mTOR in human papillary thyroid cancer cells
por: Qu, Na, et al.
Publicado: (2022)

Anti-diabetic agents for prevention of type 2 diabetes mellitus in people with pre-diabetes: a systematic review and network meta-analysis protocol
por: Wang, Xianzhe, et al.
Publicado: (2019)

Association of hypoglycaemia with the risks of arrhythmia and mortality in individuals with diabetes - a systematic review and meta-analysis
por: Li, Gangfeng, et al.
Publicado: (2023)

Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019
por: Zhang, Kexin, et al.
Publicado: (2022)

Microbiota: A potential orchestrator of antidiabetic therapy
por: Liu, Bingyao, et al.
Publicado: (2023)

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
por: Ma, Yuting, et al.
Publicado: (2021)

Efficacy of Various Antidiabetic Agents as Add-On Treatments to Metformin in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Poolsup, Nalinee, et al.
Publicado: (2012)

Comparative efficacy and safety of glucose-lowering drugs in children and adolescents with type 2 diabetes: A systematic review and network meta-analysis
por: Wu, Sijia, et al.
Publicado: (2022)

Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
por: Ma, Yuting, et al.
Publicado: (2022)

Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis
por: Gamble, JM, et al.
Publicado: (2008)

Association of metformin use with fracture risk in type 2 diabetes: A systematic review and meta-analysis of observational studies
por: Wang, Yining, et al.
Publicado: (2023)

Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis
por: Adeloye, Davies, et al.
Publicado: (2017)

Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis
por: Wei, Jinjing, et al.
Publicado: (2022)

Diabetes health coach in individuals with type 2 diabetes: A systematic review and meta analysis of quadruple aim outcomes
por: Racey, Megan, et al.
Publicado: (2022)

The efficacy and safety of evogliptin for type 2 diabetes mellitus: A systematic review and meta-analysis
por: Tang, Qizhi, et al.
Publicado: (2022)

Effect of passive smoking exposure on risk of type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies
por: Qin, Guo-Qiang, et al.
Publicado: (2023)

Advances in understanding the role and mechanisms of tumor stem cells in HER2-positive breast cancer treatment resistance (Review)
por: Xu, Linfei, et al.
Publicado: (2023)

Irisin protects against obesity-related chronic kidney disease by regulating perirenal adipose tissue function in obese mice
por: Han, Fang, et al.
Publicado: (2022)

Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Shi, Shaomin, et al.
Publicado: (2022)

Progression to type 2 diabetes mellitus after gestational diabetes mellitus diagnosed by IADPSG criteria: Systematic review and meta-analysis
por: Juan, Juan, et al.
Publicado: (2022)

Obesity Increases the Severity and Mortality of Influenza and COVID-19: A Systematic Review and Meta-Analysis
por: Zhao, Xue, et al.
Publicado: (2020)

The role of interleukin-1β in type 2 diabetes mellitus: A systematic review and meta-analysis
por: Alfadul, Hend, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rb3jkmnaeceqfhf32j4a61qdhn